Published in Del Med J on February 01, 1981
The isolation and identification of the urinary oxidative metabolites of metronidazole in man. J Pharmacol Exp Ther (1968) 2.43
Leukopenia and thrombocytopenia secondary to clinoril therapy. Lancet (1980) 1.06
Isolation and identification of the major urinary metabolite of metronidazole. Life Sci (1967) 1.01
Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther (1978) 0.99
Effect of diphenylhydantoin on glucose tolerance in patients with hypoglycemia. Diabetes (1974) 0.96
Lymphangioma in four dogs. J Am Vet Med Assoc (1978) 0.88
Phase I study of 5-azacytidine (NSC-102816) . Cancer Chemother Rep (1972) 0.88
The clinical pharmacology of meperidine--comparison of routes of administration. J Clin Pharmacol (1976) 0.85
Identification of the metabolites of metronidazole in the human vagina. Wiad Parazytol (1969) 0.83
Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis. J Clin Pharmacol (1985) 0.82
Peritoneal mesothelioma associated with diffuse abdominal ossification and unusual presentation. J Med Soc N J (1977) 0.81
Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man. Cancer Chemother Rep (1972) 0.81
Diffusion in the various zones of the normal and the rachitic growth plate. J Bone Joint Surg Am (1980) 0.81
Comparison of intramuscular dezocine with butorphanol and placebo in chronic cancer pain: a method to evaluate analgesia after both single and repeated doses. Clin Pharmacol Ther (1987) 0.80
Phase II trial of vindesine in advanced neoplastic disease. Cancer Treat Rev (1980) 0.80
The characterization of substituted nitroimidazoles on paper and thin layer chromatography by colorimetric reactions. J Chromatogr (1967) 0.80
Mutagenicity of metronidazole: structure-activity relationships. Mutat Res (1976) 0.76
Analgesic efficacy and pharmacokinetic evaluation of meperidine and hydroxyzine, alone and in combination. Cancer Invest (1983) 0.76
A potentially toxic drug interaction between pethidine (meperidine) and phenobarbitone. Lancet (1977) 0.76
Fate of streptozotocin (NSC-85998)in patients with advanced cancer. Cancer Chemother Rep (1976) 0.75
The bioavailability of meperidine using urine assays for meperidine and normeperidine. J Clin Pharmacol (1975) 0.75
Ectopic production of ACTH by a primary adenocarcinoma of the colon. J Med Soc N J (1978) 0.75
GLC determination of meperidinic and normeperidinic acids in urine. J Pharm Sci (1978) 0.75
The bioavailability of meperidine. J Clin Pharmacol (1974) 0.75
The management of the patient with chronic pain due to advanced malignancy. J Med (1982) 0.75
Response to treatment of systemic cryptococcosis in a patient with advanced malignancy: a case report. Del Med J (1982) 0.75
Drug interaction: meperidine and chlorpromazine, a toxic combination. J Clin Pharmacol (1981) 0.75
Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain. J Clin Pharmacol (1980) 0.75
Therapeutic equivalency of two lidocaine preparations. Am J Hosp Pharm (1976) 0.75
Sensitive assay for determination of hydroxyzine in plasma and its human pharmacokinetics. J Pharm Sci (1979) 0.75
The effect of phenobarbital on the metabolism of meperidine in normal volunteers. J Clin Pharmacol (1978) 0.75
Analgesic efficacy of zomepirac sodium in patients with pain due to cancer. J Clin Pharmacol (1982) 0.75
Pharmacokinetics and mechanisms of action of analgesics in clinical pain. J Clin Pharmacol (1982) 0.75
The absorption and metabolism of dibromodulcitol in patients with advanced cancer. Clin Pharmacol Ther (1972) 0.75